Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Don't plan to cook on Thanksgiving? Here are the restaurants and fast food places that are scheduled to be open - 2‘It’s Israeli policy’: Report reveals abuse of Palestinians in prisons
- 3Archaeologists uncover details about the Hjortspring boat's origins
- 4Well known SUVs With Low Energy Utilization In 2024 vote
- 5Sa'ar warns German delegation: 'A Palestinian state would be a Hamas terror state'
- Vote In favor of Your Favored Kind Of Tea
- Becoming amazing at Systems administration: Individual and Expert Tips
- 25 Years Ago, Audi's Rosemeyer Concept Was A Steampunk Supercar With A Massive Engine
- James Webb Space Telescope watches our Milky Way galaxy's monster black hole fire out a flare
- Early Thanksgiving week forecast: Where Americans can expect cold, rain and snow for the holiday
- Medicine doesn’t just have ‘conscientious objectors’ − there are ‘conscientious providers,’ too
- Most loved Public Dish: Which One Addresses Its Nation Best?
- Compassion and Association: Building Significant Connections
- The Best 15 Applications for Efficiency and Association
